Company / R&D Expense
SCYNEXIS INC R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$26.4M
FY2025
5-year range
$23.8M / $36.5M
FY2021-FY2025
Trend
-14.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $8M in FY2016 to $38M in FY2020.
Based on SEC 10-K filings.
$26M in FY2025 with a 5-year CAGR of -7.2%.
Declined from $27M to $26M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- -7.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.2%, indicating a declining trend.
- In FY2025, r&d expense decreased 14.6% year-over-year.
- Peak r&d expense was recorded in FY2020.
- Lowest r&d expense in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.39 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.4M | -14.6% |
| FY2024 | $30.9M | +13.5% |
| FY2023 | $27.3M | +14.7% |
| FY2022 | $23.8M | -34.9% |
| FY2021 | $36.5M | -4.9% |
| FY2020 | $38.4M | +78.1% |
| FY2019 | $21.6M | +17.6% |
| FY2018 | $18.3M | -8.7% |
| FY2017 | $20.1M | +142.3% |
| FY2016 | $8.3M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026